Wednesday, March 14th, 2018 - WiseGuyReports

WiseGuyReports.Com Publish a New Market Research Report On –“ U.S. Influenza Industry Pipeline Review and Outlook 2023”.

Description:                                                                                                 

Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. The common symptoms occur in influenza patients are chills, cough, running nose, sore throat, body aches, headache, fatigue, some cases people may have vomiting and diarrhea. The complication of the disease may include ear infections, bacterial pneumonia, dehydration, sinus infections, and sometimes it leads to congestive heart failure, and asthma. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the sputum, nose, or throat for the virus. A number of rapid tests are available however polymerase chain reaction that detects the virus’s RNA is more accurate. 

The U.S. Influenza market is growing at a significant CAGR due to rise in newborn babies, an increase in geriatric population. Increase in vaccination awareness, favorable reimbursement scenario, and rising investment by companies in research and development activities are the major factors fuelling the growth of U.S. influenza market over the forecast period. The major market players have great pipeline products, initiatives by government bodies such as WHO and CDC to control and prevent influenza, technological advancements in diagnostic tests also fuel the growth of U.S. influenza market over the forecast period. However, limited production capacity, a high level of required investment, and stringent regulatory policies for new product approvals might hamper the growth of U.S. Influenza market. Due to limitations in current technologies, the lengthy production times (approximately seven months), increase in prices of influenza diagnostic kits and reagents also hinder the U.S. Influenza market. 

 

Get a Sample Report @    https://www.wiseguyreports.com/sample-request/2753877-u-s-influenza-market-market-estimation-dynamics-regional-share-trends

For more information or any query mail at [email protected]

 

The U.S. Influenza market is segmented on the basis of product type, distribution channel, and end user 

Based on drug class, U.S. influenza market is segmented into the following: 
Anti-viral drugs 
Zanamivir 
Oseltamivir 
Amantadine 
Rimantadine 
Others 
Interferons 
Vaccines 
Trivalent 
Quadrivalent 

Based on the route of administration, U.S. influenza market is segmented into the following: 
Oral 
Parenteral 
Others 

Based on distribution channel U.S. influenza market is segmented into the following: 
Hospital pharmacies 
Retail pharmacies 
Others 

Influenza vaccines are key revenue contributor for the growth of U.S. influenza market. The U.S. influenza market is in growing phase, several international players are actively involved in the development of vaccines and drugs to treat influenza. The launch of new products, technological innovations, and approvals from U.S. Food and Drug Administration (FDA) for various drugs might fuel the growth of U.S. influenza market. For instance, Squires used both egg and cell-based technologies to offer the broadcast portfolio of influenza vaccines in the U.S. for both trivalent and quadrivalent formulations. Similarly, transformative changes in other vaccine markets, due to the entrance of expensive and innovative vaccines such as Gardasil (Merck) and Bexsero (GSK) are projected to contribute growth of the U.S. influenza market. 

U.S. holds a dominant share in the global influenza market. The largest share is attributed to the higher rate of in-vitro diagnostics availability and technological advancements in medical devices which are primarily driving the U.S. Influenza market growth. As per CDC, persons above 6 months of age could be vaccinated to prevent the influenza infection. Increase in prevalence and incidence cases of influenza (According to CDC, about 5 to 20 percent of the U.S. people are infected with influenza in every year. CDC also states that about 200,000 people hospitalized and more than 36,000 people are dying from influenza in U.S) might increase the growth of U.S. influenza market. Similarly, the upsurge in funding by the government is also driving the market growth in the United States. The U.S. government awarded 5-year contracts for more than US$ 1 Bn to five drug manufacturers developing technology for speedier mass production of influenza vaccines 

Some of the players in U.S. influenza market are AstraZeneca (U.K.), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Sanofi (France), Seqirus (U.K.), Protein Sciences Corporation (U.S.), Emergent Biosolutions (U.S.), BioCryst Pharmaceuticals.Inc (U.S.)., Alvogen (South Korea), Medimmune Inc. (U.S.), DynPort Vaccine Company, LLC. (U.S.), and Abbott Laboratories (U.S.) to name a few. 

In May 2016, Seqirus received approval from U.S. Food and Drug Administration for Flucelvax Quadrivalent, that was the first U.S. licensed cell-based quadrivalent influenza vaccine indicated for people aged four years and older 

In November 2016, GSK received approval from U.S. Food and Drug Administration for flulaval Quadrivalent to include use in children aged six months or older 

Report Outline: 

The report provides granular level information about the market size, regional market share, and forecast from 2017-2023 
The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies 
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry 
The report tracks recent innovations, key developments and startup’s details that are working in the industry 
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

 

Report Details @   https://www.wiseguyreports.com/reports/2753877-u-s-influenza-market-market-estimation-dynamics-regional-share-trends

 

Table Of Contents – Major Key Points

1. Executive summary 

2. U.S. Influenza Market Introduction 
    2.1. U.S. Influenza Market – Taxonomy 
    2.2. U.S. Influenza Market –Definitions 
      2.2.1. Drug Class Type 
      2.2.2. Route of Administration 
      2.2.3. Distribution Channel 

3. U.S. Influenza Market Dynamics 
    3.1. Drivers 
    3.2. Restraints 
    3.3. Opportunities/Unmet Needs of the Market 
    3.4. Trends 
    3.5. U.S. Influenza Market Dynamics – Factors Impact Analysis 
    3.6. U.S. Influenza Market – Regulations 
      3.6.1. U.S 
      3.6.2. Europe 
      3.6.3. Japan 
      3.6.4. China 
    3.7. U.S. Influenza Market – Product Innovations 

4. U.S. Influenza Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 
    4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
    4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 
    4.3. Market Oppurtunity Analysis 

5. U.S. Influenza Market, By Drug Class, 2012 - 2016 and Forecast, 2017 - 2023 
    5.1. Anti Viral Drugs 
      5.1.1. Zanamivir 
          5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
          5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 
          5.1.1.3. Market Opportunity Analysis 
      5.1.2. Oseltamivir 
          5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
          5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 
          5.1.2.3. Market Opportunity Analysis 

Continue……

For more information or any query mail at [email protected]

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Profile

WiseGuyReports


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.


Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/

Keywords

U.S. Influenza,U.S. Influenza Market,U.S. Influenza Market Share,U.S. Influenza Market Trends,U.S. Influenza Market Size,U.S. Influenza Market Opportunities,U.S. Influenza Market Growth,U.S. Influenza Market to 2023

Categories

Newsrooms

Sharing

More Formats

View QR Code